INCR InterCure: Business Value to Revenue

InterCure Ltd (INCR) - corporate logo

InterCure Ltd. is pursuing expansion into Asian and European markets, although it currently relies on its dominance in Israel through premium pricing. The EV-to-revenue multiple smooths this contrast, where the value of 1097.26 characterizes this level of market valuation. The stability of the indicator confirms balanced sales, while the introduction of new brands and CNS clinical trials drive commercial development.

InterCure Ltd. (INCR) Company Value to Revenue: for the period 11/23/2025 - 11/20/2026

Canndoc - analytical breakdowns and key metrics (INCR)

- price and consensus price forecast:
- company stock capitalization data:
Fundamental valuation:Canndoc INCR
Product sample of InterCure Ltd

The EV/Sales ratio compares the total enterprise value of a business, including debt, to its annual revenue, allowing for an assessment of the market value of one dollar of sales regardless of financial leverage. For InterCure Ltd., whose resilience is based on the diversification of medical product imports in Israel, the EV/Sales ratio trend serves as an indicator of how the market values the efficiency of complex logistics management and the protection of supply chains.